Evaluation of Antioxidant Activity and Treatment of Eczema by Berberine Hydrochloride-Loaded Liposomes-in-Gel

• Published in: Molecules (Basel, Switzerland) Switzerland), 2024-04, Vol.29 (7), p.1566
• Main Authors: Shen, Si, Qu, Xiaobo, Liu, Yinyin, Wang, Mengmeng, Zhou, Haifeng, Xia, Hongmei
• Format: Article
• Language: English
• Subjects: Animals; antioxidant capacity; Antioxidants; Antioxidants - pharmacology; Berberine - pharmacology; berberine hydrochloride; Blood vessels; Dermatologic agents; Dermatology; Drug dosages; Drug therapy; Eczema; Flavonoids; Formulae, receipts, prescriptions; Hydration; Hydrogen Peroxide; Isoflavones; Lipid Peroxides; Liposomes; liposomes-in-gel; Mice; Particle size; Permeability; Skin; Transdermal medication; Viscosity; Wound healing
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules29071566

In this paper, berberine hydrochloride-loaded liposomes-in-gel were designed and developed to investigate their antioxidant properties and therapeutic effects on the eczema model of the mouse. Berberine hydrochloride-liposomes (BBH-L) as the nanoparticles were prepared by the thin-film hydration method and then dispersed BBH-L evenly in the gel matrix to prepare the berberine hydrochloride liposomes-gel (BBH-L-Gel) by the natural swelling method. Their antioxidant capacity was investigated by the free radical scavenging ability on 2,2-diphenyl-1-picrylhydrazyl (DPPH) and H O and the inhibition of lipid peroxides malondialdehyde (MDA). An eczema model was established, and the efficacy of the eczema treatment was preliminarily evaluated using ear swelling, the spleen index, and pathological sections as indicators. The results indicate that the entrapment efficiency of BBH-L prepared by the thin-film hydration method was 78.56% ± 0.7%, with a particle size of 155.4 ± 9.3 nm. For BBH-L-Gel, the viscosity and pH were 18.16 ± 6.34 m Pas and 7.32 ± 0.08, respectively. The cumulative release in the unit area of the in vitro transdermal study was 85.01 ± 4.53 μg/cm . BBH-L-Gel had a good scavenging capacity on DPPH and H O , and it could effectively inhibit the production of hepatic lipid peroxides MDA in the concentration range of 0.4-2.0 mg/mL. The topical application of BBH-L-Gel could effectively alleviate eczema symptoms and reduce oxidative stress injury in mice. This study demonstrates that BBH-L-Gel has good skin permeability, excellent sustained release, and antioxidant capabilities. They can effectively alleviate the itching, inflammation, and allergic symptoms caused by eczema, providing a new strategy for clinical applications in eczema treatment.